ArticleJGH open : an open access journal of gastroenterology and hepatology2024

Initial treatment efficacy and safety of durvalumab plus tremelimumab combination therapy in unresectable hepatocellular carcinoma in clinical practice.

Tetsu Tomonari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.